John P. Juergens

The effects of alcohol consumption and expectancies in an experimental date rape analogue

This study examined the impact of perceived token resistance and the psychological and pharmacological effects of alcohol consumption on mens discrimination of when a female wants her partner to stop his sexual advances. In a 2 (alcohol vs. no alcohol) × 2 (expectancy vs. no expectancy) × 2 (perceived token resistance vs. no resistance) randomized factorial design, male college students were exposed to an audiotape of a date rape. Before listening, participants were told that on the previous date the woman did not resist sexual contact or that she initially objected to the contact but the man was able to obtain the level of intimacy he desired. Relative to participants assigned to the no-alcohol expectancy or no-alcohol consumption group, participants in the alcohol expectancy and alcohol consumption groups took significantly longer to determine that the man should refrain from attempting further sexual contact. The implications of the findings are discussed.

The impact of alcohol and alcohol expectancies on male perception of female sexual arousal in a date rape analog.

The impact of alcohol and alcohol expectancies on mens perception of female sexual arousal and mens ability to discriminate accurately female sexual intentions in a dating situation was examined. In a 2 (alcohol) x 2 (expectancy) balanced placebo design, men were exposed to an audiotape of a date rape and asked to signal when the man should stop making sexual advances. On 4 occasions during the vignette, participants rated how sexually aroused the woman on the tape was at that moment. Relative to controls, participants who consumed alcohol or expected to consume alcohol took significantly longer to identify the inappropriateness of the mans sexual behavior toward his date. Similarly, alcohol participants also rated the womans arousal level significantly higher at the first 2 refusals. Implications of the results are discussed.

The Synergic Impact of Promotion Intensity and Therapeutic Novelty on Market Performance of Prescription Drug Products

Multiple regression analysis was conducted to study the relationships among promotion intensity, product differentiation based on therapeutic novelty, and sales performance measured in relative market share. Especially, synergic effects of promotion intensity and therapeutic novelty on relative market share were examined. Selected as study drugs were new chemical entity drug products introduced in the United States from 1 January 1973 through 31 December 1982, which were classified into 47 different therapeutic classes. The data were obtained for the six-year period 1983 through 1988. The first multiple regression model was constructed in which relative market share was regressed on promotion and therapeutic novelty. The model explained 20.8% of the total variance. Both promotion and therapeutic novelty had significant, positive main effects on relative market share. The second model included the interaction term of promotion and therapeutic novelty, and explained 21.7% of the total variance. The interaction term was significantly positive, which suggested the synergism between promotion and therapeutic novelty.

Too Tranquil: The Epidemiology of An Idea

AbstractA review of the literature dealing with the social, professional, economic, legal, and ethical issues associated with use of minor tranquilizers revealed three studies, two literature reviews and one data source which were most frequently cited in some 100 papers which commented on utilization levels. In spite of the findings of the cited sources that such use tended to be comparatively conservative, the context of their citation suggests the reverse. the possibility exists that this and other practices which tend to err toward reducing drug use may result in undertreatment.

Physician and Patient Factors Associated with Differences in use of New Versus Established Therapeutic Agents

AbstractThe purpose of this study was to examine a secondary source of data and attempt to identify physician and patient related factors which are associated with the prescribing of new prescription drugs. Eight drugs introduced to the general market between January, 1977 and December, 1980 were selected as “new drugs” for study. Study drug utilization was compared to that of established drugs of the same therapeutic categories to determine whether there were significant differences in the relative frequencies of use between the new drugs and the established drugs with respect to physician and patient characteristics. The major conclusions of the study were 1 that treatment variables (the drug(s) examined, patient’s disease and the treatment setting) are important considerations in establishing an association between prescribing behavior and physician and patient characteristics; (2) the use of secondary data sources to study these associations can serve a limited but useful function in an overall, compr...